December 4, 2023
By Assem Dandashly, Associate Professor, Maastricht University, and Christos Kourtelis, Assistant Professor, Panteion University The opinions expressed in this article are those of the author and do not represent in any way the editorial position of Euronews. Considering the increasing tensions and international competition in a very volatile region, if the EU seeks to become a
READ MORE
Politico recently ran an important story on how the AI policy sausage-making is being done that does not appear to be getting the attention it warrants. That may be because the piece, How a billionaire-backed network of AI advisers took over Washington, tried doing too many things at once. It presents the main nodes in
READ MORE
Wipro will roll out annual hikes or merit salary increases (MSI) to its employees effective December 1. The Bengaluru-based information technology firm had postponed the hikes, due in September, by a quarter due to macro headwinds and margin pressure. The hikes will be decided on an individual basis over the next few weeks. Elevate Your
READ MORE
Yves here. Readers are sure to debate the conclusions presented below on the emissions impact of electric vehicles, but they profess to have made a very detailed analysis of the carbon cost of manufacturing and operation over a typical electric vehicle lifespan. It concludes that electric vehicles are much better than internal combustion engines. and
READ MORE
This article was originally published in Spanish In the context of global destabilisation exacerbated by Russia’s invasion of Ukraine, the 78th UN General Assembly is rethinking the relevance and effectiveness of the international institution. The 78th UN General Assembly (UNGA 78) is taking place under similar conditions to last year: Ukraine continues to defend itself against
READ MORE
Artur Widak | Nurphoto | Getty Images Moderna‘s new Covid vaccine produced a strong immune response against BA.2.86, a highly mutated omicron variant that health officials are watching closely, according to clinical trial data the biotech company released Wednesday. The updated shot produced an 8.7-fold increase in protective antibodies against BA.2.86, which has been detected
READ MORE
Artificial intelligence is increasingly moving into the health care arena and helping to streamline medical processes — including the creation of new drugs. Insilico Medicine, an AI-driven biotech company based in Hong Kong and in New York City, recently announced that its new AI-designed drug for COVID-19 has entered Phase I clinical trials. This oral
READ MORE
A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. Dado Ruvic | Reuters Novavax’s new Covid vaccine generated a broad immune response against the now-dominant Eris variant and another fast-spreading strain of the virus
READ MORE
Nikos Pekiaridis | Lightrocket | Getty Images Moderna’s new Covid vaccine generated a robust immune response against the now-dominant “Eris” variant and another rapidly spreading strain of the virus in an early clinical trial, the biotech company said Thursday. The updated shot is designed to target omicron subvariant XBB.1.5, but the results suggest that the
READ MORE
Signage is seen outside the U.S. Food and Drug Administration headquarters in White Oak, Maryland, Aug. 29, 2020. Andrew Kelly | Reuters The U.S. Food and Drug Administration has warned that some Tydemy birth control pills may not be effective, several days after the manufacturer recalled two batches of the medication that were distributed in
READ MORE